| Year |
Citation |
Score |
| 2004 |
Mytilineou C, McNaught KSP, Shashidharan P, Yabut J, Baptiste RJ, Parnandi A, Olanow CW. Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress Journal of Neural Transmission. 111: 1237-1251. PMID 15480836 DOI: 10.1007/S00702-004-0167-2 |
0.528 |
|
| 2004 |
Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Bonucelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, ... ... Mytilineou C, et al. Levodopa in the treatment of Parkinson's disease: current controversies. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 997-1005. PMID 15372588 DOI: 10.1002/Mds.20243 |
0.372 |
|
| 2004 |
Kramer BC, Mytilineou C. Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions. Journal of Neurocytology. 33: 213-23. PMID 15322379 DOI: 10.1023/B:Neur.0000030696.62829.Ec |
0.689 |
|
| 2004 |
Kramer BC, Yabut JA, Cheong J, Jnobaptiste R, Robakis T, Olanow CW, Mytilineou C. Toxicity of glutathione depletion in mesencephalic cultures: a role for arachidonic acid and its lipoxygenase metabolites. The European Journal of Neuroscience. 19: 280-6. PMID 14725622 DOI: 10.1111/J.1460-9568.2004.03111.X |
0.714 |
|
| 2003 |
Mytilineou C, Walker RH, JnoBaptiste R, Olanow CW. Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress. The Journal of Pharmacology and Experimental Therapeutics. 304: 792-800. PMID 12538835 DOI: 10.1124/Jpet.102.042267 |
0.553 |
|
| 2002 |
Mytilineou C, Kramer BC, Yabut JA. Glutathione depletion and oxidative stress. Parkinsonism & Related Disorders. 8: 385-7. PMID 12217624 DOI: 10.1016/S1353-8020(02)00018-4 |
0.722 |
|
| 2002 |
Kramer BC, Yabut JA, Cheong J, JnoBaptiste R, Robakis T, Olanow CW, Mytilineou C. Lipopolysaccharide prevents cell death caused by glutathione depletion: possible mechanisms of protection. Neuroscience. 114: 361-72. PMID 12204205 DOI: 10.1016/S0306-4522(02)00310-X |
0.721 |
|
| 2002 |
McNaught KS, Mytilineou C, Jnobaptiste R, Yabut J, Shashidharan P, Jennert P, Olanow CW. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. Journal of Neurochemistry. 81: 301-6. PMID 12064477 DOI: 10.1046/J.1471-4159.2002.00821.X |
0.458 |
|
| 1999 |
Kramer BC, Goldman AD, Mytilineou C. Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro. Brain Research. 851: 221-7. PMID 10642847 DOI: 10.1016/S0006-8993(99)02191-5 |
0.725 |
|
| 1999 |
Mytilineou C, Kokotos Leonardi ET, Kramer BC, Jamindar T, Olanow CW. Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures. Journal of Neurochemistry. 73: 112-9. PMID 10386961 DOI: 10.1046/J.1471-4159.1999.0730112.X |
0.742 |
|
| 1998 |
Leonardi ETK, Mytilineou C. Cell culture models of neuronal degeneration and neuroprotection: Implications for Parkinson's disease Advances in Experimental Medicine and Biology. 446: 203-222. PMID 10079845 DOI: 10.1007/978-1-4615-4869-0_12 |
0.37 |
|
| 1998 |
Mytilineou C, Leonardi EK, Radcliffe P, Heinonen EH, Han SK, Werner P, Cohen G, Olanow CW. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion Journal of Pharmacology and Experimental Therapeutics. 284: 700-706. PMID 9454817 |
0.504 |
|
| 1997 |
Hou JGG, Cohen G, Mytilineou C. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: Involvement of the glutathione system Journal of Neurochemistry. 69: 76-83. PMID 9202296 DOI: 10.1046/J.1471-4159.1997.69010076.X |
0.592 |
|
| 1997 |
Mytilineou C, Radcliffe PM, Olanow CW. L-(-)-desmethylselegiline, a metabolite of selegiline [L-(-)-deprenyl], protects mesencephalic dopamine neurons from excitotoxicity in vitro. Journal of Neurochemistry. 68: 434-6. PMID 8978757 DOI: 10.1046/J.1471-4159.1997.68010434.X |
0.523 |
|
| 1997 |
Mytilineou C, Radcliffe P, Leonardi EK, Werner P, Olanow CW. L-Deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro Journal of Neurochemistry. 68: 33-39. PMID 8978707 DOI: 10.1046/J.1471-4159.1997.68010033.X |
0.484 |
|
| 1996 |
Hou JGG, Mytilineou C. Secretion of GDNF by glial cells does not account for the neurotrophic effect of bFGF on dopamine neurons in vitro Brain Research. 724: 145-148. PMID 8816270 DOI: 10.1016/0006-8993(96)00311-3 |
0.514 |
|
| 1996 |
Han SK, Mytilineou C, Cohen G. L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress Journal of Neurochemistry. 66: 501-510. PMID 8592119 |
0.433 |
|
| 1996 |
Hou JGG, Lin LFH, Mytilineou C. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium Journal of Neurochemistry. 66: 74-82. PMID 8522992 DOI: 10.1046/J.1471-4159.1996.66010074.X |
0.538 |
|
| 1995 |
Shioi J, Pangalos MN, Ripellino JA, Vassilacopoulou D, Mytilineou C, Margolis RU, Robakis NK. The Alzheimer amyloid precursor proteoglycan (appican) is present in brain and is produced by astrocytes but not by neurons in primary neural cultures. The Journal of Biological Chemistry. 270: 11839-44. PMID 7744833 DOI: 10.1074/Jbc.270.20.11839 |
0.462 |
|
| 1995 |
Bouvier MM, Mytilineou C. Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 7141-9. PMID 7472468 |
0.415 |
|
| 1994 |
Bloomquist J, King E, Wright A, Mytilineou C, Kimura K, Castagnoli K, Castagnoli N. 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: Cell culture and neurotransmitter uptake studies Journal of Pharmacology and Experimental Therapeutics. 270: 822-830. PMID 8071874 |
0.387 |
|
| 1994 |
Werner P, Mytilineou C, Cohen G, Yahr MD. Impaired oxidation of pyruvate in human embryonic fibroblasts after exposure to L-dopa. European Journal of Pharmacology. 263: 157-62. PMID 7821347 DOI: 10.1016/0014-2999(94)90536-3 |
0.381 |
|
| 1993 |
Mytilineou C, Han SK, Cohen G. Toxic and protective effects of L-DOPA on mesencephalic cell cultures Journal of Neurochemistry. 61: 1470-1478. PMID 8376999 DOI: 10.1111/J.1471-4159.1993.Tb13642.X |
0.547 |
|
| 1992 |
Mytilineou C, Park TH, Shen J. Epidermal growth factor-induced survival and proliferation of neuronal precursor cells from embryonic rat mesencephalon Neuroscience Letters. 135: 62-66. PMID 1542439 DOI: 10.1016/0304-3940(92)90136-U |
0.499 |
|
| 1992 |
Park TH, Mytilineou C. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP+-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF Brain Research. 599: 83-97. PMID 1362921 DOI: 10.1016/0006-8993(92)90855-4 |
0.543 |
|
| 1991 |
Kalir HH, Mytilineou C. Ascorbic Acid in Mesencephalic Cultures: Effects on Dopaminergic Neuron Development Journal of Neurochemistry. 57: 458-464. PMID 2072096 DOI: 10.1111/J.1471-4159.1991.Tb03773.X |
0.496 |
|
| 1991 |
Casper D, Mytilineou C, Blum M. EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture Journal of Neuroscience Research. 30: 372-381. PMID 1839162 |
0.471 |
|
| 1989 |
Danias P, Nicklas WJ, Ofori S, Shen J, Mytilineou C. Mesencephalic Dopamine Neurons Become Less Sensitive to 1 ‐Methyl‐4‐Phenyl‐l,2,3,6‐Tetrahydropyridine Toxicity During Development In Vitro Journal of Neurochemistry. 53: 1149-1155. PMID 2788714 DOI: 10.1111/J.1471-4159.1989.Tb07408.X |
0.525 |
|
| 1989 |
Mytilineou C, Danias P. 6-Hydroxydopamine toxicity to dopamine neurons in culture: potentiation by the addition of superoxide dismutase and N-acetylcysteine Biochemical Pharmacology. 38: 1872-1875. PMID 2735944 DOI: 10.1016/0006-2952(89)90426-7 |
0.508 |
|
| 1988 |
Mytilineou C, Friedman L. Studies on the Metabolism and Toxicity of l‐Methyl‐4‐Phenyl‐l,2,3,6‐Tetrahydropyridine in Cultures of Embryonic Rat Mesencephalon Journal of Neurochemistry. 51: 750-755. PMID 2970526 DOI: 10.1111/J.1471-4159.1988.Tb01809.X |
0.475 |
|
| 1987 |
Mytilineou C, Cohen G. Tissue culture model for studying MPTP toxicity to dopamine neurons Advances in Neurology. 45: 145-148. PMID 3493622 |
0.396 |
|
| 1987 |
Friedman L, Mytilineou C. The toxicity of MPTP to dopamine neurons in culture is reduced at high concentrations Neuroscience Letters. 79: 65-72. PMID 2890125 DOI: 10.1016/0304-3940(87)90673-2 |
0.521 |
|
| 1985 |
Mytilineou C, Cohen G. Deprenyl Protects Dopamine Neurons from the Neurotoxic Effect of 1‐Methyl‐4‐Phenylpyridinium Ion Journal of Neurochemistry. 45: 1951-1953. PMID 3932598 DOI: 10.1111/J.1471-4159.1985.Tb10556.X |
0.52 |
|
| 1985 |
Cohen G, Mytilineou C. VII. Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Life Sciences. 36: 237-242. PMID 3917526 DOI: 10.1016/0024-3205(85)90065-7 |
0.535 |
|
| 1985 |
Mytilineou C, Cohen G, Heikkila RE. 1-methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture Neuroscience Letters. 57: 19-24. PMID 3875812 DOI: 10.1016/0304-3940(85)90034-5 |
0.542 |
|
| 1984 |
Mytilineou C, Cohen G. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalon Science. 225: 529-531. PMID 6610939 DOI: 10.1126/Science.6610939 |
0.52 |
|
| 1983 |
Mytilineou C, Cohen G, Dembiec-Cohen D, Van Woert M, Hwang E. Explant cultures of dog substantia nigra and striatum: a model for the study of nigro-striatal dopamine neurons Journal of Neural Transmission, Supplement. 19: 37-51. PMID 6321649 |
0.412 |
|
| 1981 |
Whetsell WO, Mytilineou C, Shen J, Yahr MD. The development of the dog nigrostriatal system in organotypic culture. Journal of Neural Transmission. 52: 149-61. PMID 7310391 DOI: 10.1007/Bf01249600 |
0.35 |
|
| 1981 |
Rubenstein AE, Mytilineou C, Yahr MD, Pearson J, Goldstein M. Neurotransmitter analysis of dermal neurofibromas: implications for the pathogenesis and treatment of neurofibromatosis. Neurology. 31: 1184-8. PMID 6115338 DOI: 10.1212/Wnl.31.9.1184 |
0.412 |
|
| 1978 |
Issidorides MR, Mytilineou C, Whetsell WO, Yahr MD. Protein-rich cytoplasmic bodies of substantia nigra and locus ceruleus. A comparative study in parkinsonian and normal brain. Archives of Neurology. 35: 633-7. PMID 697603 DOI: 10.1001/Archneur.1978.00500340009002 |
0.301 |
|
| 1976 |
Mytilineou C, Black IB. Regeneration of sympathetic neurons: effect of decentralization. Brain Research. 109: 382-6. PMID 6122 DOI: 10.1016/0006-8993(76)90538-2 |
0.303 |
|
| 1976 |
Black IB, Mytilineou C. The interaction of nerve growth factor and trans-synaptic regulation in the development of target organ innervation by sympathetic neurons. Brain Research. 108: 199-204. PMID 6113 DOI: 10.1016/0006-8993(76)90178-5 |
0.304 |
|
| 1972 |
Cohen G, Mytilineou C, Barrett RE. 6,7-dihydroxytetrahydroisoquinoline: Uptake and storage by peripheral sympathetic nerve of the rat Science. 175: 1269-1272. PMID 5061251 DOI: 10.1126/Science.175.4027.1269 |
0.33 |
|
| Show low-probability matches. |